Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?

被引:0
作者
Cosimo De Bari
机构
[1] Institute of Medical Sciences,Regenerative Medicine Group, Musculoskeletal Research Programme
[2] University of Aberdeen,undefined
来源
Arthritis Research & Therapy | / 17卷
关键词
Rheumatoid Arthritis; Mesenchymal Stem Cell; Rheumatoid Arthritis Patient; Articular Cartilage; Bone Marrow MSCs;
D O I
暂无
中图分类号
学科分类号
摘要
The advancements in our understanding of the inflammatory and immune mechanisms in rheumatoid arthritis (RA) have fuelled the development of targeted therapies that block cytokine networks and pathogenic immune cells, leading to a considerable improvement in the management of RA patients. Nonetheless, no therapy is curative and clinical remission does not necessarily correspond to non-progression of joint damage. Hence, the biomedical community has redirected scientific efforts and resources towards the investigation of other biological aspects of the disease, including the mechanisms driving tissue remodelling and repair. In this regard, stem cell research has attracted extraordinary attention, with the ultimate goal to develop interventions for the biological repair of damaged tissues in joint disorders, including RA. The recent evidence that mesenchymal stem cells (MSCs) with the ability to differentiate into cartilage are present in joint tissues raises an opportunity for therapeutic interventions via targeting intrinsic repair mechanisms. Under physiological conditions, MSCs in the joint are believed to contribute to the maintenance and repair of joint tissues. In RA, however, the repair function of MSCs appears to be repressed by the inflammatory milieu. In addition to being passive targets, MSCs could interact with the immune system and play an active role in the perpetuation of arthritis and progression of joint damage. Like MSCs, fibroblast-like synoviocytes (FLSs) are part of the stroma of the synovial membrane. During RA, FLSs undergo proliferation and contribute to the formation of the deleterious pannus, which mediates damage to articular cartilage and bone. Both FLSs and MSCs are contained within the mononuclear cell fraction in vitro, from which they can be culture expanded as plastic-adherent fibroblast-like cells. An important question to address relates to the relationship between MSCs and FLSs. MSCs and FLSs could be the same cell type with functional specialisation or represent different functional stages of the same stromal lineage. This review will discuss the roles of MSCs in RA and will address current knowledge of the relative identity between MSCs and FLSs. It will also examine the immunomodulatory properties of the MSCs and the potential to harness such properties for the treatment of RA.
引用
收藏
相关论文
共 360 条
[11]  
Bezemer PD(2004)Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes J Exp Med. 200 1673-9
[12]  
Boers M(2007)Cadherin-11 in synovial lining formation and pathology in arthritis Science. 315 1006-10
[13]  
Dijkmans BA(2010)Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture Arthritis Rheum. 62 742-52
[14]  
Cohen G(2004)BMP receptor signaling is required for postnatal maintenance of articular cartilage PLoS Biol. 2 62-73
[15]  
Gossec L(2008)A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis Dev Biol. 316 257-71
[16]  
Dougados M(2010)Mesenchymal stem cells from development to postnatal joint homeostasis, aging, and disease Birth Defects Res C Embryo Today. 90 669-75
[17]  
Cantagrel A(2006)Synovial fibroblasts: key players in rheumatoid arthritis Rheumatology (Oxford). 45 17432-7
[18]  
Goupille P(2006)An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes Proc Natl Acad Sci U S A. 103 393-403
[19]  
Daures JP(1970)The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells Cell Tissue Kinet. 3 71-4
[20]  
Diarra D(1997)Marrow stromal cells as stem cells for nonhematopoietic tissues Science. 276 143-7